Deep Track Capital »

Definium Therape shares owned by Deep Track Capital

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $57M 3.0M 18.90

More positions owned by Deep Track Capital

Spdr Series Trust State Street Spd Put Option (XBI)
Guardant Health (GH)
Immunovant (IMVT)
Tarsus Pharmaceuticals (TARS)
Vaxcyte (PCVX)
Structure Therapeutics Sponsored Ads (GPCR)
Axsome Therapeutics (AXSM)
Apellis Pharmaceuticals (APLS)
Ocular Therapeutix (OCUL)
Vera Therapeutics Cl A (VERA)
Alumis (ALMS)
Ionis Pharmaceuticals (IONS)
Nuvalent Inc-a (NUVL)
Alkermes SHS (ALKS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)

View all positions for Deep Track Capital

Top funds holding Definium Therape

BlackRock
Driehaus Capital Management
Henderson Group
Deep Track Capital
Marshall Wace
Geode Capital Management
Octagon Capital Advisors
Commodore Capital
Trails Edge Capital Partners
Goldman Sachs Group
Arrowpoint Asset Management
Citadel Advisors
Candriam Luxembourg S.C.A.
Balyasny Asset Management
Two Sigma Investments

View all funds holding Definium Therape